Armata Pharmaceuticals, Inc. Common Stock (ARMP) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Armata Pharmaceuticals, Inc. Common Stock · Cost of Revenue

ARMP Cost of Revenue

Latest reported$1.05Mperiod endingJun 30, 2026

ARMP Cost of Revenue (-$400.00K → $1.05M)

Annual cost of revenue

High-resolution chart · PNG

ARMP cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Armata Pharmaceuticals, Inc. Common Stock Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	1,531,000
Dec 31, 2024	34,426,000
Dec 31, 2023	972,000
Dec 31, 2022	35,017,000
Dec 31, 2021	20,015,000
Dec 31, 2020	14,444,000
Dec 31, 2019	1,351,000
Dec 31, 2018	1,351,000
Dec 31, 2017	374,000
Dec 31, 2016	369,000
Dec 31, 2015	0
Dec 31, 2014	0
Dec 31, 2013	82,000
Dec 31, 2012	0
Dec 31, 2009	12,171,000
Dec 31, 2008	15,183,000
Dec 31, 2007	17,709,000
Dec 31, 2006	14,482,000
Dec 31, 2005	18,199,000
Dec 31, 2004	17,288,000
Dec 31, 2003	17,197,000
Dec 31, 2002	29,754,000
Dec 31, 2001	37,615,000
Dec 31, 2000	-1,775,000
Dec 31, 1999	-1,600,000
Dec 31, 1998	-1,600,000
Dec 31, 1997	-1,600,000
Dec 31, 1996	-1,900,000
Dec 31, 1995	-1,400,000
Dec 31, 1994	-1,300,000
Dec 31, 1993	-400,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.